BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 9345319)

  • 1. Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides.
    Sabini E; Hazra S; Konrad M; Lavie A
    J Med Chem; 2007 Jun; 50(13):3004-14. PubMed ID: 17530837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity?
    Verri A; Montecucco A; Gosselin G; Boudou V; Imbach JL; Spadari S; Focher F
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):585-90. PubMed ID: 9895305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral influences of feedback inhibition with dCTP on murine deoxycytidine kinase.
    Tomikawa A; Yamaguchi T; Kawaguchi T; Shudo K; Saneyoshi M
    Nucleic Acids Symp Ser; 1997; (37):181-2. PubMed ID: 9586059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide specificity of human deoxycytidine kinase.
    Shewach DS; Reynolds KK; Hertel L
    Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase.
    Johansson M; Karlsson A
    Biochem Pharmacol; 1995 Jul; 50(2):163-8. PubMed ID: 7632159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: a model for nucleoside kinase action.
    Turk B; Awad R; Usova EV; Björk I; Eriksson S
    Biochemistry; 1999 Jun; 38(26):8555-61. PubMed ID: 10387103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate.
    Hughes TL; Hahn TM; Reynolds KK; Shewach DS
    Biochemistry; 1997 Jun; 36(24):7540-7. PubMed ID: 9200705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NTP phosphate donor in kinase reactions: is ATP a monopolist?
    Shugar D
    Acta Biochim Pol; 1996; 43(1):9-23. PubMed ID: 8790708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular targets of antitumor 2'-deoxycytidine analogues.
    Obata T; Endo Y; Murata D; Sakamoto K; Sasaki T
    Curr Drug Targets; 2003 May; 4(4):305-13. PubMed ID: 12699351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life on the salvage path: the deoxynucleoside kinase of Lactobacillus acidophilus R-26.
    Ives DH; Ikeda S
    Prog Nucleic Acid Res Mol Biol; 1998; 59():205-55. PubMed ID: 9427844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chiral discrimination of 2'-deoxy-L-cytidine and L-nucleotides by mouse deoxycytidine kinase: low stereospecificities for substrates and effectors.
    Tomikawa A; Kohgo S; Ikezawa H; Iwanami N; Shudo K; Kawaguchi T; Saneyoshi M; Yamaguchi T
    Biochem Biophys Res Commun; 1997 Oct; 239(1):329-33. PubMed ID: 9345319
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.